Larry Lee Miller, Chief Operating Officer of Phibro Animal Health Corp (NASDAQ: PAHC), filed a Form 4 on August 10, 2026, disclosing the acquisition of 3,522 restricted stock units of Class A Common Stock on August 6, 2026.

Key Highlights

  • Reporting person: Larry Lee Miller, identified as Chief Operating Officer of Phibro Animal Health Corp.
  • Grant size: 3,522 restricted stock units (RSUs) of Class A Common Stock were acquired on August 6, 2026, at a price of $0.
  • Vesting schedule: The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2026, subject to continued employment through each applicable vesting date.
  • Security type: Each RSU represents a contingent right to receive one share of Class A Common Stock.
  • Beneficial ownership following transaction: Miller directly holds 38,071 shares of Class A Common Stock following the reported transaction.

RSU Award Details and Ownership Position for Phibro Animal Health COO

According to the filing, Larry Lee Miller, Chief Operating Officer of Phibro Animal Health Corp, acquired 3,522 restricted stock units on August 6, 2026. The transaction was recorded under Transaction Code "A," indicating an acquisition. The price per unit was reported as $0, consistent with a grant rather than a market purchase. The filing notes that each RSU "represents a contingent right to receive one share of Class A Common Stock."

The filing specifies that the RSUs "vest in substantially equal installments on each of the first three anniversaries of August 1, 2026, subject to the Reporting Person's continued employment through the applicable vesting date." Following this transaction, Miller's direct beneficial ownership of Class A Common Stock stands at 38,071 shares, according to the filing. The form was filed by one reporting person, and no indirect beneficial ownership was reported in connection with this transaction.

The Form 4 was signed by Judith Weinstein as Attorney-in-Fact for Larry Lee Miller and submitted to the SEC on August 10, 2026. No derivative securities transactions were reported in Table II of the filing.

What Was Disclosed

The filing discloses a grant of 3,522 RSUs of Class A Common Stock to Phibro Animal Health Corp's Chief Operating Officer on August 6, 2026, vesting over three years, with resulting direct beneficial ownership of 38,071 shares.